“…PPIs have a much longer duration of action than histamine H 2 -receptor antagonists (the effects last up to one week or more after stopping therapy). Furthermore, because of their extended potency at suppressing acid secretion, PPIs cause hypergastrinemia in 80–100% of non-ZES patients, in ranges that overlap with most ZES patients [45, 48, 60, 65, 67–70, 103–105]. Therefore, to differentiate the source of the hypergastrinemia (appropriate due to drug induced acid suppression or inappropriate as in ZES), almost all guidelines, recommended PPIs be stopped for at least a week prior to gastric analysis.…”